Research undertaken at the Watanabe Laboratory
Professor Akira Watanabe and his laboratory are building upon the foundations laid by Yamanaka. Based within the Center for iPS Cell Research and Application (CIRA) at Kyoto University, Japan, the Watanabe Laboratory uses iPS cells to study epigenesis and all of the potential that it affords.
One of the key avenues of investigation is on building a model of epigenesis using a series of single cell devices including the Fluidigm's C1 system, 10XGenomics's Chromium, Clontech's ICELL8 and Bio-Rad's ddSEQ and the Illumina's HiSeq2000 sequencer. These devices allow researchers to prepare single cell templates for mRNA sequencing, DNA sequencing, epigenetics or miRNA expression. Importantly, the technology enables users to survey cell diversity, identify rare cell types and characterise cellular functions, all on the same single cell biology platform. iPS cells undergo a series of stages when they are differentiating into their final cell state. Current understanding suggests that each stage depends on different factors and, until now, identifying the different factors has proved extremely difficult. With that in mind, Watanabe and his team have worked to develop single cell analysis tools to enable them to identify the factors.
Keywords: CELL DIVERSITY; CELL FATE REGULATION; CELL-BASED THERAPEUTICS; CHARACTERISE CELLULAR FUNCTION; DNA SEQUENCING; EPIGENESIS; EPIGENETICS; EPIGENOME INTEGRITY; IDENTIFY RARE CELL TYPES; IPS CELL-BASED THERAPIES; IPS CELL-BASED THERAPY; IPS CELLS; MIRNA EXPRESSION; MRNA SEQUENCING; PLURIPOTENT STEM CELLS; REGENERATIVE MEDICINE; RETINAL PIGMENT EPITHELIA; SINGLE CELL GENOMICS RESEARCH
Document Type: Research Article
Publication date: December 1, 2018
Impact is a series of high-quality, open access and free to access science reports designed to enable the dissemination of research impact to key stakeholders. Communicating the impact and relevance of research projects across a large number of subjects in a content format that is easily accessible by an academic and stakeholder audience. The publication features content from the world's leading research councils, policy groups, universities and research projects. Impact is published under a CC-BY Creative Commons licence.
- Subscribe to this Title
- Terms & Conditions
- Disseminating research in Impact
- Information about Impact
- Ingenta Connect is not responsible for the content or availability of external websites